NASDAQ:SLIM Obesity ETF (SLIM) Price, Holdings, & News → The Next Nvidia? (From InvestorPlace) (Ad) Free SLIM Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$33.17▼$33.1750-Day Range$33.17▼$33.1752-Week Range$31.59▼$43.40VolumeN/AAverage Volume4,086 shsMarket Capitalization$9.95 millionAssets Under Management$13.68 millionDividend Yield0.66%Net Expense Ratio0.50% Stock AnalysisStock Analysis Get Obesity ETF alerts: Email Address About Obesity ETF (NASDAQ:SLIM)Read More Ad InvestorPlaceThe Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.Go here now for this breaking story. SLIM ETF News HeadlinesMay 5, 2024 | seekingalpha.comAmgen Could Become A Real Contender In The Obesity MarketMay 2, 2024 | ca.finance.yahoo.comAt least 25,000 people in the US are starting weight-loss drug Wegovy each week, drugmaker saysMay 5, 2024 | InvestorPlace (Ad)The Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.May 1, 2024 | markets.businessinsider.comGoldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity and Diabetes DrugsApril 25, 2024 | yahoo.com3 Foods That Make It Ridiculously Hard to Lose Belly Fat, According to Obesity Medicine DocsApril 16, 2024 | msn.comChildhood Obesity May Be Linked to Iron Deficiency, According to New Study from the British Journal of MedicineApril 11, 2024 | yahoo.comStruggling with obesityApril 2, 2024 | yahoo.comChildren with obesity have higher MS risk, study suggestsMay 5, 2024 | InvestorPlace (Ad)The Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.March 22, 2024 | reuters.comObesity drugs inch closer to outsize expectationsSee More Headlines Receive SLIM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Obesity ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerJanus Henderson Fund NameThe Obesity ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:SLIM Inception Date6/8/2016 Fund ManagerBenjamin Wang, Scott M. Weiner WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkSolactive Obesity Index CategorySector FocusHealth Care Development LevelBlended Development RegionGlobal Number of Holdings0 Fund Statistics Assets Under Management$13.68 million Average Daily Volume$2,330.30 Discount/Premium-0.38% Administrator, Advisor and Custodian AdministratorJanus Capital Management LLC AdvisorJanus Capital Management LLC CustodianState Street Bank and Trust Company DistributorALPS Distributors, Inc. Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares300,000BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Ad InvestorPlaceThe Next Nvidia?The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.Go here now for this breaking story. Obesity ETF ExpensesTypeSLIMHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.50%0.56%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.34%0.58%Total Expense0.50%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.53%-0.55%-0.22%-0.57%Net Expense0.50%0.60%0.60%0.54%0.58% Obesity ETF (SLIM) ExposureSLIM Sector ExposureSLIM Industry ExposureFull Holdings Details Similar ETFsHorizon Kinetics Medical ETFNASDAQ:MEDXFirst Trust Nasdaq Pharmaceuticals ETFNASDAQ:FTXHJPMorgan Healthcare Leaders ETFNASDAQ:JDOCProShares UltraShort Nasdaq BiotechnologyNASDAQ:BISInvesco Nasdaq Biotechnology ETFNASDAQ:IBBQ SLIM ETF - Frequently Asked Questions What does SLIM invest in? Obesity ETF is a equity fund issued by Janus Henderson. SLIM focuses on health care investments and follows the Solactive Obesity Index. The fund's investments total to approximately $13.68 million assets under management. What is the management fee for Obesity ETF? Obesity ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for SLIM is 0.50%. What other stocks do shareholders of Obesity ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Obesity ETF investors own include Supernus Pharmaceuticals (SUPN), Teva Pharmaceutical Industries (TEVA), Nightstar Therapeutics (NITE), ServiceNow (NOW), Silicon Laboratories (SLAB), Trinity Biotech (TRIB), Tata Motors (TTM), United Parcel Service (UPS), Vodafone Group Public (VOD) and Winnebago Industries (WGO). This page (NASDAQ:SLIM) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Obesity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.